Therapeutic Area market research reports by DelveInsight

• Dyspepsia- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Dyspepsia- Pipeline Insight, 2024 DelveInsight’s, “Dyspepsia- Pipeline Insight, 2024” report provides comprehensive insights about 2+ companies and 2+ pipeline drugs in Dyspepsia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cove ... Read More

• Myopia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Myopia - Pipeline Insight, 2024 DelveInsight’s, “Myopia - Pipeline Insight, 2024” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Myopia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More

• Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Skin And Skin Structure Infections (SSSI) Caused By Bacteria - Pipeline Insight, 2024 Skin And Skin Structure Infections (SSSI) Caused By Bacteria Overview ""Skin And Skin Structure Infections (SSSI) Caused By Bacteria Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of ... Read More

• Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne - Pipeline Insight, 2024 Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Overview ""Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present cli ... Read More

• Female Trichomoniasis Vaginalis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Female Trichomoniasis Vaginalis - Pipeline Insight, 2024 Female Trichomoniasis Vaginalis Overview ""Female Trichomoniasis Vaginalis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Female Trichomon ... Read More

• Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Glaucoma - Pipeline Insight, 2024 DelveInsight’s, “Glaucoma Disease- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Glaucoma Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• Glioma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 5,000

  Glioma - Pipeline Insight, 2024 DelveInsight’s, “Glioma - Pipeline Insight, 2024” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Glioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More

• Anemia Associated with Chronic Kidney - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Anemia Associated with Chronic Kidney - Pipeline Insight, 2024 Anemia Associated with Chronic Kidney Overview ""Anemia Associated with Chronic Kidney Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across th ... Read More

• Persistant Angina Pain - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Persistant Angina Pain - Pipeline Insight, 2024 Persistant Angina Pain Overview ""Persistant Angina Pain Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Persistant Angina Pain market. A detailed p ... Read More

• Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024 DelveInsight’s, “Inflammation and Pain Post Cataract Surgery – Pipeline Insight, 2024,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Inflammation and Pain Post Cataract Surgery pipeline landsca ... Read More

• Age-related vision dysfunction - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Age-related vision dysfunction - Pipeline Insight, 2024 Age-related vision dysfunction Overview ""Age-related vision dysfunction Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Age-related vision ... Read More

• AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024 AIDS Related Kaposi's Sarcoma Overview ""AIDS Related Kaposi's Sarcoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the AIDS Related Kaposi's ... Read More

• Geographic Atrophy (GA)- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Geographic Atrophy (GA)- Pipeline Insight, 2024 DelveInsight’s, “Geographic Atrophy - Pipeline Insight, 2024, report provides comprehensive insights about 23+ companies and 25+ pipeline drugs in Geographic Atrophy pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights The Fuchs Endothelial Corneal Dystrophy (FECD) market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of FECD in the 7MM is expected to increase, driven by th ... Read More

• CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More

• Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024 Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Overview ""Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insig ... Read More

• Single Ventricle Heart Disease - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Single Ventricle Heart Disease - Pipeline Insight, 2024 Single Ventricle Heart Disease Overview ""Single Ventricle Heart Disease Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Single Ventricle He ... Read More

• Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) - Pipeline Insight, 2024 Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Overview ""Hospital-Acquired & Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Pipeline Insight, 2024"" report by DelveIn ... Read More

• Uveitic Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Uveitic Glaucoma - Pipeline Insight, 2024 Uveitic Glaucoma Overview ""Uveitic Glaucoma Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Uveitic Glaucoma market. A detailed picture of the Uveitic Gl ... Read More

• Thymus Cancer - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Thymus Cancer - Pipeline Insight, 2024 Thymus Cancer Overview ""Thymus Cancer Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Thymus Cancer market. A detailed picture of the Thymus Cancer pipeline ... Read More

• Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024 Undifferentiated Pleomorphic Sarcoma (UPS) Overview ""Undifferentiated Pleomorphic Sarcoma (UPS) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth pros ... Read More

• Traumatic Brain Injury(TBI) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Traumatic Brain Injury(TBI) - Pipeline Insight, 2024 Traumatic Brain Injury(TBI) Overview ""Traumatic Brain Injury(TBI) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Traumatic Brain Injury(TBI) ... Read More

• Postmenopausal Vaginal Atrophy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Postmenopausal Vaginal Atrophy - Pipeline Insight, 2024 Postmenopausal Vaginal Atrophy Overview ""Postmenopausal Vaginal Atrophy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Postmenopausal Vagi ... Read More

• Vulvovaginal Candidiasis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Vulvovaginal Candidiasis - Pipeline Insight, 2024 DelveInsight’s, “Vulvovaginal Candidiasis - Pipeline Insight, 2024,” report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Vulvovaginal Candidiasis pipeline landscape. It covers the pipeline drug profiles, including clini ... Read More

• Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Therapy Resistant Psychiatric Disorders - Pipeline Insight, 2024 Therapy Resistant Psychiatric Disorders Overview ""Therapy Resistant Psychiatric Disorders Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects acr ... Read More

< prev 15 16 17 18 19 20 21 22 23 24 next >